Patents/Assignees

Dyne Therapeutics, Inc.

47 patents in portfolio

US12496352utility2025
Muscle Targeting Complexes and Uses Thereof for Treating Myotonic Dystrophy
0 cites
US12478687utility2025
United States
0 cites
US12460011utility2025
Complexes Comprising an Anti-transferrin Receptor Antibody Linked to an Oligonucleotide and Method of Delivering an Oligonucleotide to a Subject
0 cites
US12440574utility2025
Muscle Targeting Complexes and Formulations for Treating Myotonic Dystrophy
0 cites
US12440575utility2025
Muscle Targeting Complexes and Uses Thereof for Treating Dystrophinopathies
0 cites
US12428487utility2025
Complexes Comprising an Anti-transferrin Receptor Antibody Linked to an Oligonicleotide and Method of Delivering Oligonucleotide to a Subject
0 cites
US12403203utility2025
Muscle Targeting Complexes and Uses Thereof for Treating Dystrophinopathies
0 cites
US12397062utility2025
Muscle Targeting Complexes and Uses Thereof for Treating Dystrophinopathies
0 cites
US12370264utility2025
Complexes Comprising an Anti-transferrin Receptor Antibody Linked to an Oligonucleotide and Method of Delivering Oligonucleotide to a Subject
0 cites
US12357703utility2025
Muscle-targeting Complexes Comprising an Anti-transferin Receptor Antibody Linked to an Oligonucleotide and Method of Use Thereof to Induce Exon Skipping
0 cites
US12329824utility2025
Muscle Targeting Complexes and Uses Thereof for Treating Dystrophinopathies
0 cites
US12329825utility2025
Muscle Targeting Complexes Comprising an Anti-transferrin Receptor Antibody Linked to an Oligonucleotide and Method of Use Thereof to Induce Exon Skipping of Exon 44 of Dystrophin in a Subject
0 cites
US12325753utility2025
Method of Using an Anti-transferrin Receptor Antibody to Deliver an Oligonucleotide to a Subject Having Facioscapulohumeral Muscular Dystrophy
0 cites
US12319743utility2025
Complexes Comprising an Anti-transferrin Receptor Antibody Linked to an Oligonucleotide and Method of Delivering Oligonucleotide to a Subject
0 cites
US12280122utility2025
Muscle Targeting Complexes and Uses Thereof for Treating Myotonic Dystrophy
0 cites
US12263225utility2025
Muscle-targeting Complexes Comprising an Anti-transferrin Receptor Antibody Linked to an Oligonucleotide and Methods of Use Thereof to Target Dystrophin and to Treat Duchenne Muscular Dystrophy
0 cites
US12239716utility2025
Muscle Targeting Complexes and Uses Thereof for Treating Dystrophinopathies
0 cites
US12239717utility2025
Muscle Targeting Complexes and Uses Thereof for Treating Dystrophinopathies
0 cites
US12173078utility2024
Complexes Comprising an Anti-transferrin Receptor Antibody Linked to an Oligonucleotide
0 cites
US12173079utility2024
Muscle-targeting Complexes Comprising an Anti-transferrin Receptor Antibody Linked to an Oligonucleotide
0 cites

Page 1 of 3Next →